3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
8
Leukemia, Myeloid, Acute
8
Multiple Myeloma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Hematologic Neoplasms
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
5
Waldenstrom Macroglobulinemia
4
Myeloproliferative Disorders
4
Lymphoma, Non-Hodgkin
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma
2
Leukemia, Prolymphocytic
2
Leukemia, Myelomonocytic, Chronic
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Bronchiolitis Obliterans Syndrome
2
Anemia, Aplastic
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Soft Tissue Neoplasms
1
Sezary Syndrome
1
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Sirolimus
×
90 days
×
Clear all
No trials found.